Somatostatin Receptors

Cat. No.

A41619

CAS No.

204318-14-9

Edotreotide

Synonyms: DOTATOC; SDZ-SMT 487; SMT 487

Edotreotide is a selective ligand for the somatostatin receptor subtype 2 (SSTR2), capable of competitive binding to the receptor. It facilitates the targeted delivery of radionuclides, such as 90Y, 177Lu, and 68Ga, to SSTR-positive tumors, promoting tumor cell apoptosis through the emission of β rays. Edotreotide's strong tumor-targeting capabilities make it a valuable tool in the development of radionuclide-drug conjugates (RDCs) and in research applications focused on neuroendocrine tumors, including metastatic carcinoids and lung and thymus neuroendocrine tumors.

Cat. No.

A41632

CAS No.

619300-53-7

DOTA-NOC

Synonyms: DOTA-Nal3-octreotide

DOTA-NOC (DOTA-Nal3-octreotide) is a high-affinity ligand for somatostatin receptor subtypes 2, 3, and 5. This compound is primarily utilized for radiolabeling with various radiometals, facilitating the development of radiopeptide imaging techniques. Additionally, DOTA-NOC plays a crucial role in the synthesis and research of Radionuclide-Drug Conjugates (RDCs), making it a valuable reagent in oncological and diagnostic studies.

Cat. No.

A63892

CAS No.

709043-21-0

NOTA-TATE

NOTA-TATE is a selective somatostatin receptor 2 (SSTR2) binder. It specifically targets SSTR2-positive tumor cells, facilitating their visualization through PET imaging. This compound is particularly valuable in the research of neuroendocrine tumors, advancing both diagnostic and therapeutic applications in oncology.